NCT04115033View on ClinicalTrials.gov

Randomized Controlled Trial of CES for Fibromyalgia

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 2, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Fibromyalgia
Interventions
DEVICE

Alpha-stim

The device for both groups is the Alpha-stim, a FDA-approved device similar to the Military Field Stimulator (MFS/Neuro-Stim System), a cranial electrical stimulation (CES) device.

Trial Locations (1)

30033-4004

Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur

All Listed Sponsors
lead

VA Office of Research and Development

FED